Koshinski Asset Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Koshinski Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$548.35 - $738.84 $205,082 - $276,326	-374 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$595.12 - $698.43 $120,809 - $141,781	-203 Reduced 35.18%	374 $261 Million
Q3 2021 Oct 12, 2021	BUY	$574.03 - $680.96 $331,215 - $392,913	577 New	577 $349,000
Q2 2021 Jul 26, 2021	SELL	$472.8 - $558.54 $218,906 - $258,604	-463 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$446.73 - $548.2 $35,738 - $43,856	-80 Reduced 14.73%	463 $219,000
Q4 2020 Mar 30, 2021	BUY	$478.3 - $607.98 $124,358 - $158,074	260 Added 91.87%	543 $262,000
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $135,358 - $172,058	283 New	283 $262,000
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $259,716 - $330,133	-543 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $43,580 - $52,656	-80 Reduced 12.84%	543 $327,000
Q2 2020 Jul 29, 2020	BUY	$493.32 - $643.92 $32,065 - $41,854	65 Added 11.65%	623 $389,000
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $187,588 - $275,891	558 New	558 $272,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.